Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.86 USD
Change Today +0.0388 / 4.70%
Volume 2.2M
XOMA On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Patrick J. Scannon M.D., Ph.D.

Founder, Chief Scientific Officer, Executive Vice President and Director,XOMA Corporation
AgeTotal Calculated CompensationThis person is connected to 52 board members in 5 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Patrick J. Scannon, also known as Pat, M.D., Ph.D., co-Founded Xoma Corporation in 1980 and has been its Executive Vice President since May 2006 and has been its Chief Scientific Officer since February 2011. Mr. Scannon served as the Chief Medical Officer of Xoma Corporation since March 2009 and its Chief Biotechnology Officer from May 2006 to March 2009, Chief Scientific & Medical Officer from March 1993 to 2006 and its Senior Vice President. Mr. Scannon served ...

Read Full Background

Corporate Headquarters*

2910 Seventh Street
Berkeley, California 94710

United States

Phone: 510-204-7200
Fax: --

Board Members Memberships*

Founder, Chief Scientific Officer, Executive Vice President and Director
Independent Director


University of California Berkeley
Medical College Of Georgia

Other Affiliations*

Annual Compensation*

Total Annual Compensation$250,262

Stock Options*

Restricted Stock Awards$387,122
All Other Compensation$18,434
Exercised Options20,000
Exercised Options Value$126,242
Exercisable Options321,985
Exercisable Options Value$71,939
Unexercisable Options95,296
Unexercisable Options Value$20,085
Total Value of Options$218,265
Total Number of Options437,281

Total Compensation*

Total Annual Cash Compensation$347,529
Total Short Term Compensation$250,262
Other Long Term Compensation$405,556
Total Calculated Compensation$1,132,535
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XOMA:US $0.86 USD +0.0388


Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
John Peter McLaughlin J.D.Chief Executive Officer, President, Director and Member of Litigation Committee
PDL BioPharma, Inc.
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
Tim Van Hauwermeiren MSc, EMBAChief Executive Officer and Executive Director
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XOMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at